ACELYRIN
SLRN
SLRN was delisted on the 21st of May, 2025.
2 hedge funds and large institutions have $704 invested in ACELYRIN in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 105 closing their positions.
73.41% less ownership
Funds ownership: 73.41% → 0% (-73%)
98% less funds holding
Funds holding: 105 → 2 (-103)
98% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 105
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $183M → $704 (-$183M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$654 |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
+$7 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$24.3M |
| 2 |
ACMC
AyurMaya Capital Management Company
Portsmouth,
New Hampshire
|
-$23.1M |
| 3 |
BlackRock
New York
|
-$14.3M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$11.5M |
| 5 |
MAP
Madison Avenue Partners
New York
|
-$10.2M |
SLRN Hedge Fund Activity: Q2 2025 in Review
2 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in ACELYRIN (SLRN) for Q2 2025, worth a combined $704 — down 100% from $183M a quarter earlier.
Sellers outnumbered buyers: 105 funds closed out of SLRN and 2 opened new positions — a net loss of 103 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Osaic Holdings, opening a new position worth an estimated $654. The largest seller was Tang Capital Management, exiting entirely with an estimated $24.3M sold.
- 2 institutional investors held ACELYRIN (SLRN) as of Q2 2025, down from 105 in Q1 2025.
- Funds reported $704 of ACELYRIN stock for Q2 2025, down 100% quarter-over-quarter.
- 2 funds opened new ACELYRIN positions in Q2 2025 and 105 closed out, a net change of -103 holders.
- The largest ACELYRIN buyer in Q2 2025 was Osaic Holdings, an estimated $654 added.
- The largest ACELYRIN seller in Q2 2025 was Tang Capital Management, an estimated $24.3M sold.
Based on aggregated 13F filings for Q2 2025.